Skip to content

Cognitive Impairment and Imaging Correlates in End Stage Renal Disease

Cognitive Impairment and Imaging Correlates in End Stage Renal Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01883349
Enrollment
120
Registered
2013-06-21
Start date
2013-03-31
Completion date
2023-09-30
Last updated
2024-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Brief summary

This is an observational cohort to understand cognitive impairment in end stage renal disease before and after a kidney transplant.

Detailed description

Cognitive impairment is very common in patients with End Stage Renal Disease (ESRD). It exact mechanisms are not clear, but patients with ESRD have more cerebral white matter changes. Several studies have shown that cognitive function improves post-transplant, indicating that there may be some reversibility in the process. This study will examine the correlation between cognitive impairment and structural brain changes before and after renal transplantation. We will also study the correlation of cognitive function with serum inflammatory markers before and after transplant. These results will be compared to aged matched healthy controls without kidney disease.

Interventions

PROCEDUREKidney Transplant

Kidney Transplant Surgery

OTHERNo kidney transplant

The control group was made up of subjects without ESRD and were not on the renal transplantation waitlist.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Pre-transplant ESRD patients who are listed for renal transplantation * Able to sign pre-transplant consent on their own will * Have english as their native language

Exclusion criteria

* Current use of antipsychotics or anti-epileptics * Inability to read or write which will limit their ability to perform the cognitive tests * Claustrophobia or inability to get MRI for other reasons * Unable to sign consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Cognitive FunctionChange from Baseline to 3 Months and 12 Months after Renal TransplantCognition will be assessed using relevant neuropsychological tests used by National Alzheimers Coordination center (NACC) uniform data set (UDS). Primary outcome will be logical memory. Score range 0-25. Higher scores indicate better cognitive function.

Secondary

MeasureTime frameDescription
Change in inflammatory markersChange from Baseline to 3 months and 12 months post transplant
Change in verbal declarative/episodic memoryChange from Baseline to 3 Months and 12 Months after Renal TransplantWMS-R Logical Memory I- Immediate is a test where a brief story is read to subject, who is then asked to retell it from memory immediately; primary measure of performance is number of story units recalled. Scores are from 0-25 with higher scores indicating better cognition.
Change in delayed verbal declarative/episodic memoryChange from Baseline to 3 Months and 12 Months after Renal TransplantWMS-R Logical Memory II- Delayed measures delayed recall of story read to the participant at the beginning of testing session (WMS-R Logical Memory I- Immediate). Scores range from 0-25 with higher scores indicating better cognition.
Change in brain MRIChange from Baseline to 3 Months and 12 months after Renal TransplantBrain MRI will be performed before and after transplant
Change in general dementia screening scoreChange from Baseline to 3 Months and 12 Months after Renal TransplantMini-Mental State Examination Screening scale evaluates orientation to place, orientation to time, registration, attention and concentration, recall, language, and visual construction. Scores range from 0-30 with higher scores indicate better cognition.
Change in working memory or attentionChange from Baseline to 3 Months and 12 Months after Renal TransplantDigit Span forward and backward are tests where a subject is read sequences of increasing length and asked to repeat them. Digit span length is the length of the highest digit sequence the subject is able to repeat correctly. Scores range from 0-12 with higher scores indicate better cognition.
Change in psychomotor speed and visuospatial functionChange from Baseline to 3 Months and 12 Months after Renal TransplantWAIS-R Digit Symbol Substitution test is where a subject is given a key consisting of numbers 1-9, each paired with a unique, easy-to-draw symbol; subject fills in corresponding symbol for each number in a limited time. Scores are from 0-133 with higher scores indicating better cognition.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026